Aastrom to Host Second Quarter 2012 Investor Call on August 7, 2012
Equities.com
2, 2012 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific, expanded multicellular therapies for the treatment of severe, chronic cardiovascular diseases, will hold a second quarter investor call on ...

and more »


More...